The Authors' Reply: Organoid Technology: Are Human Cholangiocyte Organoids Immune Protected?

Ivo J. Schurink, Jeroen De Jonge, Luc J.W. Van Der Laan*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

We thank Ekser et al for reading our commentary on the groundbreaking Science publication by Sampaziotis et al on repair of bile ducts after transplantation of cholangiocyte organoids in human liver grafts. Ekser et al comment that if allogenic cholangiocyte organoids would be used for graft repair, this potentially can provoke an alloimmune response. The authors are “puzzled by the outcome of the original paper as nonautologous organoids were used and no protective immunosuppressive medication is used during the normothermic machine perfusion of the liver grafts.” [...]
Original languageEnglish
Pages (from-to)E250
JournalTransplantation
Volume106
Issue number4
DOIs
Publication statusPublished - Apr 2022

Bibliographical note

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Fingerprint

Dive into the research topics of 'The Authors' Reply: Organoid Technology: Are Human Cholangiocyte Organoids Immune Protected?'. Together they form a unique fingerprint.

Cite this